Washington et al., 1988 - Google Patents
An investigation into the floating behaviour of a pectin-containing anti-reflux formulation (FF5005) by means of gamma scintigraphyWashington et al., 1988
View PDF- Document ID
- 17149546170140805356
- Author
- Washington N
- Wilson C
- Greaves J
- Danneskiold-Samsøe P
- Publication year
- Publication venue
- Scandinavian journal of gastroenterology
External Links
Snippet
The gastric distribution and residence time of a new pectin-containing formulation, FF5005 (Farma Food A/S, Denmark), was investigated by using the technique of gamma scintigraphy in six healthy volunteers after administration with a radiolabelled meal. The …
- 239000000203 mixture 0 title abstract description 39
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2710375B2 (en) | Antacid composition | |
| Doscherholmen et al. | Impaired assimilation of egg Co57 vitamin B12 in patients with hypochlorhydria and achlorhydria and after gastric resection | |
| Malmud et al. | Scintigraphic evaluation of gastric emptying | |
| Davis et al. | The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet) | |
| Davis et al. | A comparative study of the gastrointestinal transit of a pellet and tablet formulation | |
| Holgate et al. | Relationship between small bowel transit time and absorption of a solid meal influence of metoclopramide, magnesium sulfate, and lactulose | |
| McIntyre et al. | Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors. | |
| Watts et al. | The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis | |
| Scolapio | Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study | |
| Rigaud et al. | Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study | |
| Datz et al. | Gender-related differences in gastric emptying | |
| Wilding et al. | In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy | |
| Adkin et al. | Colonic transit of different sized tablets in healthy subjects | |
| Welch et al. | Regulation of gastric emptying by ileal nutrients in humans | |
| Grossman et al. | Gastric acid does drive pancreatic bicarbonate secretion | |
| Hampson et al. | Alginate–antacid combinations: raft formation and gastric retention studies | |
| Jian et al. | Gastric emptying and intragastric distribution of lipids in man: a new scintigraphic method of study | |
| Kleibeuker et al. | Cholecystokinin is a physiological hormonal mediator of fat‐induced inhibition of gastric emptying in man | |
| Neal et al. | The effect of resection of the distal ileum on gastric emptying, small bowel transit and absorption after proctocolectomy | |
| Washington et al. | An investigation into the floating behaviour of a pectin-containing anti-reflux formulation (FF5005) by means of gamma scintigraphy | |
| Nielsen et al. | Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome | |
| Rydning et al. | The effect of guar gum and fiber-enriched wheat bran on gastric emptying of a semisolid meal in healthy subjects | |
| Iftikhar et al. | The effect of pectin on the gastric emptying rates and blood glucose levels after a test meal | |
| Washington et al. | Gastric distribution and residence time of two anti-reflux formulations | |
| Sagar et al. | Technetium-99m labelled bran: a new agent for measuring gastric emptying |